MORRISVILLE, N.C.--(BUSINESS WIRE)--TearScience, Inc., a privately-held medical device company, today announced that it has received U.S. Food and Drug Administration (FDA) clearance for its next ...

A Morrisville-based company has gotten clearance from the U.S. Food and Drug Administration to market and sell a technology used to help people with dry eyes. A Morrisville-based company has gotten ...

SANTA ANA, Calif., July 24, 2021 /PRNewswire/ -- Johnson & Johnson Vision*, a global leader in eye health and part of the Johnson & Johnson Medical Devices Companies**, today revealed new comparative ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. NEW YORK — LipiFlow single-use activators will soon cost ...

Medical device company TearScience has secured $15 million in debt financing that the company will use to support a pair of products addressing evaporative dry eye. An estimated 100 million people ...

DURHAM, N.C.--(BUSINESS WIRE)--TearScience, Inc., a venture funded medical device company, today announced that Duke Eye Center, an academic research and education-based university eye care center, ...

Medical device company TearScience has received 510(k) clearance on the latest version of its evaporative dry eye treatment. The Morrisville, North Carolina company’s novel dry eye treatment initially ...

Dealing with dry, irritated eyes is a constant battle for many, but thanks to a new device developed by a company in the Triangle, some people who have struggled to find effective treatments are ...

Please provide your email address to receive an email when new articles are posted on . LOS ANGELES — TearScience has introduced the LipiFlow Activator II, a ...

February ended with big funding news in the med tech world: HealthCare Royalty Partners' commitment of up to $70 million in debt financing to TearScience, the North Carolina maker of a dry eye ...

TearScience Inc., a Morrisville-based medical device company, announced Monday it has received FDA approval to market and sell its treatment for evaporative dry eye. TearScience Inc., a ...

Six years after a blockbuster $40 million funder, Morrisville-based TearScience is at it again, raising a new $19.3 million in equity financing. Six years after a blockbuster $40 million funder, ...